SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Qualified Opinion who wrote (3060)8/14/2002 9:56:19 AM
From: biostruggle  Read Replies (1) | Respond to of 10345
 
I do not know why anyone is debating Myobloc at this point. It seems Elan has not even come up with the appropriate dose and scheduling to even begin Phase IV trials. Myobloc is now at least 2 years away from market for cosmetic use. Elan is better selling it off for whatever they can get for it and let a larger company handle the problems.



To: Qualified Opinion who wrote (3060)8/14/2002 10:18:57 AM
From: William Partmann  Respond to of 10345
 
<Bill, you may belong on Yahoo.>

Rob, think before you post. It's not hard.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News